FDA recall, , Moderate risk
SnapshotGLO Wound Imaging Device
The SnapshotGLO Wound Imaging Device can become temporarily unusable when its battery fully discharges into shipping mode.
Summary by Recall Canary from the FDA notice
What happened
KENT IMAGING, INC. of Calgary, Canada recalled the SnapshotGLO Wound Imaging Device, Model KB100 and KB100AA, because the software controlling the battery charging circuit was not designed to recognize and recover a battery that has fully discharged into a low-power shipping mode.
When this occurs, an affected device will not resume charging when reconnected to power and becomes temporarily unusable for wound imaging until corrected. The company began the recall on June 30, 2026, and the FDA added it to the Enforcement Report on July 22, 2026. The device was distributed nationwide in the states of PA, IA, FL, TX, GA, NV, CA, UT, IN, DC, KS, IL, TN, AR, and AZ.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:
- A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
- Talk to your health care provider before you stop using it.
Is yours affected?
Affected if its model number is listed.
SnapshotGLO Wound Imaging Device
- Model number
- KB100
- KB100AA
Recall details
- Company began the recall
- Sold in
US Nationwide distribution in the states of Pennsylvania, Iowa, Florida, Texas, Georgia, Nevada, California, Utah, Indiana, District of Columbia, Kansas, Illinois, Tennessee, Arkansas, Arizona.
- Company
- KENT IMAGING, INC.Calgary, Canada
- Hazard
- Software defect
- Risk
Moderate risk
Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99406
- Recall number
- Z-2775-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
